Quantcast

Latest Personalized medicine Stories

2014-09-23 23:02:21

OMICS Group International is elated to launch its 4th International Conference and Exhibition on Metabolomics and Systems Biology during April 27-29, 2015 at Philadelphia, USA, focusing on the

2014-09-19 04:21:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular) has announced the addition of the

2014-09-16 16:28:44

LONDON, Sept.

2014-09-16 12:31:31

SAN DIEGO, Sept. 16, 2014 /PRNewswire/ -- Denovo Biopharma, LLC, today announced that it has acquired enzastaurin, a late-stage oncology drug, from Eli Lilly and Company (NYSE: LLY).

2014-09-12 08:23:43

Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif., Sept.

2014-09-11 12:27:47

Selected to Showcase Healthcare Innovation at TEDMED WASHINGTON, Sept.

2014-09-10 08:32:36

- Findings and research approach published in Nature Communications - CAMBRIDGE, Mass., Sept.

2014-09-09 20:24:58

ReportsnReports.com adds "Companion Diagnostics Market by Technology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical


Word of the Day
dynamitard
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.